Graft-versus-host disease: Have we solved the problem?

Journal of Clinical Oncology

Volumn 30, Issue 26, 2012, Pages 3160-3161

  Giralt, Sergio ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORTEZOMIB; CYCLOPHOSPHAMIDE; CYCLOSPORIN; HLA ANTIGEN; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; CANCER RECURRENCE; CANCER RELAPSE; CANCER SURVIVAL; CHRONIC GRAFT VERSUS HOST DISEASE; DISEASE FREE SURVIVAL; EDITORIAL; GRAFT INFECTION; GRAFT VERSUS HOST REACTION; HLA TYPING; HUMAN; IMMUNOPROPHYLAXIS; MYELOID LEUKEMIA; PRIORITY JOURNAL;

ANTIGENS, CD34; BORONIC ACIDS; FEMALE; GRAFT VS HOST DISEASE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOID, ACUTE; LYMPHOCYTE DEPLETION; MALE; PYRAZINES; SIBLINGS; T-LYMPHOCYTE SUBSETS;

EID: 84866527431     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.43.3201     Document Type: Editorial

References (14)

1. Thomas ED, Buckner CD, Banaji M, et al: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49:511-533, 1977 (Pubitemid 8080182)
2. de la Morena MT, Gatti RA: A history of bone marrow transplantation. Hematol Oncol Clin North Am 25:1-15, 2011
3. Gooley TA, Chien JW, Pergam SA, et al: Reduced mortality after allogeneic hematopoietic-cell transplantation. N Engl J Med 363:2091-2101, 2010
4. Wingard JR, Majhail NS, Brazauskas R, et al: Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. J Clin Oncol 29:2230-2239, 2011
5. Koreth J, Stevenson KE, Kim HT, et al: Bortezomib-based graft versus host disease prophylaxis in HLA-mismatched unrelated donor transplantation. J Clin Oncol 30:3202-3208, 2012
6. Luznik L, O'Donnell PV, Symons HJ, et al: HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 14:641-650, 2008 (Pubitemid 351664058)
7. Socié G, Schmoor C, Bethge WA, et al: Chronic graft-versus-host disease: Long-term results from a randomized trial on graft-versus-host disease prophylaxis with or without anti-T-cell globulin ATG-Fresenius. Blood 117:6375-6382, 2011
8. Pasquini MC, Devine S, Mendizabal A, et al: Comparative outcomes of donor graft CD34+ selection and immune suppressive therapy as graft-vs-host disease prophylaxis for patients with acute myeloid leukemia in complete remission undergoing HLA-matched sibling allogeneic hematopoietic cell transplantation. J Clin Oncol 30:3194-3201, 2012
9. Devine SM, Carter S, Soiffer RJ, et al: Low risk of chronic graft-versus-host disease and relapse associated with T cell-depleted peripheral blood stem cell transplantation for acute myelogenous leukemia in first remission: Results of the blood and marrow transplant clinical trials network protocol 0303. Biol Blood Marrow Transplant 17:1343-1351, 2011
10. Wingard JR, Carter SL, Walsh TJ, et al: Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation. Blood 116:5111-5118, 2010
11. Wagner JE, Thompson JS, Carter SL, et al: Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): A multi-centre, randomised phase II-III trial. Lancet 366:733-741, 2005 (Pubitemid 41207235)
12. Storb R, Antin JH, Cutler C: Should methotrexate plus calcineurin inhibitors be considered standard of care for prophylaxis of acute graft-versus-host disease? Biol Blood Marrow Transplant 16:S18-S27, 2010
13. Weisdorf D, Carter S, Confer D, et al: Blood and marrow transplant clinical trials network (BMT CTN): Addressing unanswered questions. Biol Blood Marrow Transplant 13:257-262; discussion 255-256, 2007
14. Ferrara JL, Anasetti C, Stadtmauer E, et al: Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007. Biol Blood Marrow Transplant 13:1268-1285, 2007 (Pubitemid 47576946)